Mark Patrick - Syngenta CFO, Member of the Executive Committee
CFO
Mr. Mark Patrick was Chief Financial Officer, Member of the Executive Committee at Syngenta Ltd since 2016. Prior to his appointment as Chief Financial Officer, he was Head Commercial Finance at Syngenta . Prior to that, he was Head Crop Protection Finance, Head Finance North America Crop Protection, Head Business Reporting and APAC Regional Supply Finance Head Syngenta in Hong Kong. He joined AstraZeneca in 1993. Mr. Patrick holds no other mandates in the supreme executive bodies of listed or nonlisted companies. He is a Chartered Management Accountant and also holds an honors degree in Quantity Surveying and a postgraduate degree in Economics. since 2016.
| Age | 48 |
| Tenure | 8 years |
| Phone | 41 61 323 1111 |
| Web | http://www.syngenta.com |
Syngenta Management Efficiency
The company has return on total asset (ROA) of 5.85 % which means that it generated a profit of $5.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.45 %, meaning that it generated $12.45 on every $100 dollars invested by stockholders. Syngenta's management efficiency ratios could be used to measure how well Syngenta manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 5.63 B in total debt with debt to equity ratio (D/E) of 63.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Syngenta AG has a current ratio of 1.6, which is within standard range for the sector. Debt can assist Syngenta until it has trouble settling it off, either with new capital or with free cash flow. So, Syngenta's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Syngenta AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Syngenta to invest in growth at high rates of return. When we think about Syngenta's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 2 records | CFO Age | ||
| Howard Millar | Ryanair Holdings PLC | 56 | |
| Scott Yessner | Universal Technical Institute | 47 | |
Management Performance
| Return On Equity | 12.45 | |||
| Return On Asset | 5.85 |
Syngenta AG Leadership Team
Elected by the shareholders, the Syngenta's board of directors comprises two types of representatives: Syngenta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Syngenta. The board's role is to monitor Syngenta's management team and ensure that shareholders' interests are well served. Syngenta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Syngenta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew McConville, Investor Relations Contact Officer | ||
| Jeff Rowe, President Global Seeds and North America, Member of the Executive Committee | ||
| Christoph Maeder, Member of the Executive Committee, Head of Legal & Taxes, Secretary | ||
| John Ramsay, Interim CEO and CFO | ||
| Jonathan Seabrook, Head of Corporate Affairs | ||
| Sophie KornowskiBonnet, Non-Executive Independent Director | ||
| Mark Titterington, Head Corporate Affairs | ||
| Davor Pisk, COO | ||
| Gaoning Ning, Non-Executive Chairman of the Board | ||
| Jianxin Ren, Non-Executive Chairman of the Board | ||
| Gunnar Brock, Non-Executive Independent Director | ||
| Eleni GabreMadhin, Non-Executive Director | ||
| Jonathan Parr, COO | ||
| Vinita Bali, Non-Executive Independent Director | ||
| Mark Peacock, Head of Global Operations | ||
| Stefan Borgas, Non-Executive Director | ||
| John Atkin, COO | ||
| Hongbo Chen, Non-Executive Director | ||
| David Lawrence, Non-Executive Director | ||
| Michel Demare, Chairman of the Board | ||
| Olivier ClermontTonnerre, Non-Executive Director | ||
| Carl Casale, Non-Executive Independent Director | ||
| Stephen Landsman, Group General Counsel, Member of the Executive Committee | ||
| Caroline Luscombe, Head of HR | ||
| Dieter Gericke, Non-Executive Director | ||
| Alexandra Brand, Chief Sustainability Officer | ||
| Patricia Malarkey, Head Research & Development | ||
| Jacques Vincent, Non-Executive Director | ||
| Juerg Witmer, Non - Executive Vice Chairman of the Board | ||
| Eveline Saupper, Non-Executive Director | ||
| Alexander Tokarz, Head Business Development | ||
| Jennifer Gough, IR Contact Officer | ||
| Mark Patrick, CFO, Member of the Executive Committee | ||
| Erik Fyrwald, CEO | ||
| Laure Roberts, Head Human Resources | ||
| Paul Fribourg, Non-Executive Director |
Syngenta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Syngenta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 12.45 | |||
| Return On Asset | 5.85 | |||
| Profit Margin | 8.26 % | |||
| Operating Margin | 16.20 % | |||
| Current Valuation | 45 B | |||
| Shares Outstanding | 92.33 M | |||
| Price To Earning | 40.86 X | |||
| Price To Book | 4.83 X | |||
| Price To Sales | 3.46 X | |||
| Revenue | 12.62 B |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Syngenta Pink Sheet
If you are still planning to invest in Syngenta AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syngenta's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |